Inhibition of metastasis of lewis lung carcinoma by a synthetic peptide within growth factor‐like domain of urokinase in the experimental and spontaneous metastasis model

International Journal of Cancer

Volumn 57, Issue 5, 1994, Pages 727-733

  Kobayashi, Hiroshi ^a   Gotoh, Junko ^a   Fujie, Michio ^a   Shinohara, Hiromitsu ^a   Moniwa, Nobuhiko ^a   Terao, Toshihiko ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SYNTHETIC PEPTIDE; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CONTROLLED STUDY; FEMALE; INTRAVENOUS DRUG ADMINISTRATION; LEWIS CARCINOMA; LUNG METASTASIS; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

AMINO ACID SEQUENCE; ANIMAL; CARCINOMA; FEMALE; FLOW CYTOMETRY; GROWTH SUBSTANCES; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PEPTIDES; RECEPTORS, CELL SURFACE; URINARY PLASMINOGEN ACTIVATOR;

EID: 0028287392     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.2910570520     Document Type: Article

References (22)

1. A rapid in vitro assay for quantititating the invasive potential of tumor cells
2. The receptor‐binding sequence of urkinase
3. Expression of human recombinant plasminogen activators enhances invasion and experimental metastasis of H‐ras‐transformer NIH3T3 cells
4. The receptor for urokinase‐pasminogen activator
5. Plasminogen activators, tissue degradation, and cancer
6. Characterization of the cellular binding site for the urokinase‐type plasminogen activator
7. Modulation of metastatic potential by cell surface urokinase of murine melanoma cells
8. Saturation of tumour cell surface receptor for urokinase‐type plasminogen activator by amino‐terminal fragment and subsequent effect on reconstituted basement membranes invasion
9. Inhibition of in vitro ovarian cancer cell invasion by modulation of urokinase‐type plasminogen activator and cathepsin B
10. Cathepsin B efficiently activates the soluble and the tumor cell receptor‐bound form of the proenzyme urokinase‐type plasminogen activator (pro‐uPA)
11. Tumor invasion and metastasis: an imbalance of positive and negative regulation
12. In vivo invasion of modified chorioallantoic membrane by tumor cells: the role of cell surface‐bound urokinase
13. Antibodies to plasminogen activator inhibit human tumor metastasis
14. Selective inhibition of proteolytic enzymes in an invitro mouse model for experimental metastasis
15. Biological and clinical relevance of the urokinase‐type plasminogen activator (uPA) in breast cancer
16. Immunocytochemical localization of urokinase‐type plasminogen activator in Lewis lung carcinoma
17. Autocrine saturation of pro‐urokinase receptors on human A431 cells
18. Macrophage plasminogen activator: induction by concanvalin A and phorbol myristate aceate
19. Plasminogen activator in cultured Lewis lung carcinoma cells measured by chromogenic substrate assay
20. Plasminogen activator specific inhibitors in mouse macrophages: in vivo and in vitro modulation of their synthesis and secretion
21. Relationship between secreted urokinase plasminogen activator activity and metastatic potential in murine B16 cells transfected with human urokinase sense and antisense genes